Nicotinell Fruit (Nicotine Polacrilex)

Nicotine Polacrilex, the active ingredient in Nicotinell Fruit, is a nicotine replacement therapy presented as a buccal delivery system for buccal use. It is intended to help adults who are trying to quit smoking by providing controlled nicotine exposure to reduce withdrawal symptoms.\n\nGNH India supplies Nicotinell Fruit as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicotinell Fruit, a nicotine replacement therapy, is used to support individuals who are trying to quit tobacco smoking.\n\n- Smoking cessation: helps reduce cravings and withdrawal symptoms associated with quitting smoking, facilitating a gradual reduction in nicotine dependence.\n- Nicotine dependence: provides a controlled source of nicotine to replace cigarettes, allowing users to taper their intake under professional guidance.

Common side effects are generally mild and related to the buccal route of administration.\n\nCommon Side Effects:\n- Mouth irritation: soreness or discomfort in the oral cavity.\n- Nausea: feeling of queasiness after use.\n- Headache: mild to moderate headache episodes.\n- Taste disturbance: altered or unpleasant taste perception.\n\nSerious or Rare Side Effects:\n- Allergic reaction: rash, itching, or swelling that may require medical attention.\n- Throat swelling: significant edema that could affect breathing.\n- Severe mouth ulceration: painful lesions that persist beyond normal use.

Before initiating therapy, consider the following safety measures.\n\n- Assess cardiovascular status: evaluate patient history for recent myocardial infarction or uncontrolled hypertension.\n- Avoid use in recent myocardial infarction: contraindicated in patients with a recent heart attack.\n- Pregnancy and lactation: do not use unless the potential benefit outweighs the risk to the fetus or infant.\n- Monitor for nicotine toxicity: advise patients to report symptoms such as dizziness, rapid heartbeat, or nausea.\n- Store at ambient temperature: keep in the original packaging, protect from moisture and heat.

Nicotine can influence the pharmacokinetics or pharmacodynamics of several medicines.\n\nMajor Interactions (Avoid):\n- MAO inhibitors: may increase the risk of hypertensive crisis.\n- Insulin: nicotine may affect glucose control, requiring dose adjustments.\n- Warfarin: nicotine can alter metabolism, potentially affecting anticoagulation.\n\nModerate Interactions (Monitor Closely):\n- Beta‑blockers: nicotine may mask tachycardia, complicating cardiovascular monitoring.\n- CYP1A2 substrates (e.g., theophylline): nicotine induces enzyme activity, possibly reducing drug efficacy.